SCHEMBL22414882

SCHEMBL22414882

Clc1ccc2c(c1)c1ccccc1c1occ(-c3ccccc3)c21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ RXFP1 Q9HBX9 1/20 0.39
▸ ALOX15 P16050 3/20 0.39
▸ ALOX12 P18054 3/20 0.39
▸ PIK3CA P42336 2/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ HPGD P15428 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ THRB P10828 1/20 0.36
▸ ELANE P08246 1/20 0.36
▸ AHR P35869 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.35
▸ ADORA3 P0DMS8 2/20 0.35
▸ PIN1 Q13526 1/20 0.35
▸ TNKS O95271 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22414942 1.00 KMT2A (0.39) KMT2AMEN1RXFP1ALOX15ALOX12
SCHEMBL22414879 0.95 KMT2A (0.40) KMT2AMEN1RXFP1ALOX15ALOX12
SCHEMBL22414867 0.95 KMT2A (0.40) KMT2AMEN1RXFP1ALOX15ALOX12
SCHEMBL22414717 0.86 ALOX15 (0.42) KMT2AMEN1ALOX15ALOX12SMN1; SMN2
SCHEMBL20624108 0.78 KMT2A (0.49) KMT2AMEN1RXFP1SMN1; SMN2ALDH1A1
SCHEMBL12126675 0.77 KMT2A (0.54) KMT2AMEN1RXFP1SMN1; SMN2ALDH1A1
SCHEMBL12126663 0.76 KMT2A (0.53) KMT2AMEN1RXFP1SMN1; SMN2ALDH1A1
SCHEMBL22414654 0.75 CA1 (0.44) SMN1; SMN2ALDH1A1HPGDMAPK1AHR
SCHEMBL22414955 0.75 CA1 (0.44) SMN1; SMN2ALDH1A1HPGDMAPK1AHR
SCHEMBL22943124 0.73 KMT2A (0.54) KMT2AMEN1RXFP1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230127951-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO LTD (KR) 2023-04-27 — — US disclosed
US-20230127951-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO LTD (KR) 2023-04-27 — — US disclosed
US-20200283426-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2020-09-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230127951-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SLC25A21, SLCO4C1, SLCO2A1 KMT2A 2908/4885MEN1 2735/4885RXFP1 4684/4885
US-20200283426-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE USE1, SLC16A1, SLCO4C1 KMT2A 2572/4885MEN1 1809/4885RXFP1 4368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback